HTLV I/II

Serological Confirmatory Test Resolves Indeterminate Results

Published in Blood Weekly, May 3rd, 1999

A new serological confirmatory test for human T-cell leukemia virus resolved results for many indeterminate and positive-untypeable blood samples often observed by Western blot assays.

Recently, a new HTLV confirmatory assay (INNO-LIA HTLV I/II Ab [INNO-LIA]; Innogenetics, Ghent, Belgium) appeared to be useful in resolving indeterminate results by WB for well-defined HTLV sera (Zrein et al., Clin Diagn Lab Immunol, 1998;5:45-59).

Ester C. Sabino of Brazil's Fundacao Pro-Sangue and colleagues said this development prompted them to compare the new test with a commercial Western blot (WB) assay. As samples they used a large number of blood donations...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1999-05-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry